BRIEF published on 02/06/2025 at 18:05, 1 year 4 months ago LNA Santé annonce une croissance robuste en 2024 malgré les défis réglementaires Croissance Internationale Performance Financière Défis Réglementaires Prévisions Pour 2025 Soins Ambulatoires
BRIEF published on 02/06/2025 at 18:03, 1 year 4 months ago Chiffre d'affaires 2024 de LNA Santé : croissance et perspectives Croissance Organique Hospitalisation À Domicile Chiffre D'affaires 2024 Perspectives 2025 Soins Ambulatoires
BRIEF published on 02/06/2025 at 18:03, 1 year 4 months ago LNA Santé 2024 turnover: growth and outlook Organic Growth 2024 Turnover Outlook 2025 Home Hospitalization Outpatient Care
REGULATED PRESS RELEASE published on 02/06/2025 at 18:00, 1 year 4 months ago LNA SANTE : Q4 2024 LNA Santé reports strong activity in 2024 with operating revenue of €793.9m, driven by growth in outpatient care. Strategic choices confirmed by business momentum. 2025 sales growth projected at +6.0% LNA Santé Operating Revenue Outpatient Care 2024 Activity 2025 Sales Growth
REGULATED PRESS RELEASE published on 02/06/2025 at 17:58, 1 year 4 months ago LNA SANTE : Chiffre d'affaires annuel 2024 LNA Santé annonce une croissance de 10,3% du CA Exploitation en 2024, portée par le développement des soins ambulatoires et l'activité immobilière. Prévision de croissance de 6,0% en 2025 Croissance LNA Santé CA Exploitation Activité Ambulatoire Prévision 2025
BRIEF published on 02/05/2025 at 09:46, 1 year 4 months ago LNA Santé : Répartition du Capital et des Droits de Vote au 31 Janvier 2025 Capital Société Générale LNA Santé Droits De Vote Réglementation
BRIEF published on 02/05/2025 at 09:46, 1 year 4 months ago LNA Santé: Distribution of Capital and Voting Rights as of January 31, 2025 Voting Rights Capital Regulation LNA Health General Society
REGULATED PRESS RELEASE published on 02/05/2025 at 09:41, 1 year 4 months ago LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/01/2025 Déclaration de répartition du capital et des droits de vote de Société Générale au 31/01/2025 Capital Déclaration Société Générale Droits De Vote Réglementation
BRIEF published on 01/09/2025 at 09:49, 1 year 5 months ago LNA Santé : Répartition de capital et droits de vote au 31 décembre 2024 LNA Santé Droits De Vote Actions Franchissements De Seuil Répartition Capital
BRIEF published on 01/09/2025 at 09:49, 1 year 5 months ago LNA Santé: Distribution of capital and voting rights as of December 31, 2024 Voting Rights Actions Capital Distribution LNA Health Threshold Crossings
Published on 06/26/2026 at 13:00, 9 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 11 hours 29 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 13 hours 39 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 14 hours 39 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/26/2026 at 12:18, 50 minutes ago EQS-Adhoc: EPH Group AG: EPH Group AG Extends Subscription Period for New EPH Shares Until 31 July 2026
Published on 06/26/2026 at 11:30, 1 hour 39 minutes ago Amundi Index Solutions: NOTICE TO SHAREHOLDERS
Published on 06/26/2026 at 11:14, 1 hour 54 minutes ago EQS-Adhoc: Evonik Industries AG: Current financial and forecast data for the second quarter of 2026 and adjustment of the outlook for the financial year 2026
Published on 06/26/2026 at 11:05, 2 hours 3 minutes ago Join the Beautiful Game: Discover Immersive Fan Experiences with Hisense at FIFA World Cup 2026™
Published on 06/26/2026 at 07:00, 6 hours 9 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 6 hours 9 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 18 hours 24 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 18 hours 39 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
